Where does Suzhou Ribo Life Science Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Suzhou Ribo Life Science Co., Ltd. ranks #18,154 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Suzhou Ribo Life Science Co., Ltd. hold?

Suzhou Ribo Life Science Co., Ltd. holds 16 US utility patents granted between 2016 and 2025, spanning 10 technology areas.

What is Suzhou Ribo Life Science Co., Ltd.'s Innovation Score?

Suzhou Ribo Life Science Co., Ltd. has an Innovation Score of 55.8 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Suzhou Ribo Life Science Co., Ltd.'s patent grant rate increasing or decreasing?

Suzhou Ribo Life Science Co., Ltd.'s recent grant velocity is +80% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Suzhou Ribo Life Science Co., Ltd.'s patents?

Suzhou Ribo Life Science Co., Ltd.'s patents average 24.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Suzhou Ribo Life Science Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Suzhou Ribo Life Science Co., Ltd.

Q: What technology areas does Suzhou Ribo Life Science Co., Ltd. focus on?

Suzhou Ribo Life Science Co., Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 14 patents, ranking #748 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Suzhou ranks #18,154 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 10 technology areas.

#18,154
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.8/100): 24.7
avg claims per patent: +80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18154 · Foreign Corporation #18,154 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #18,154/49,997
PHOTO-FINISH Sachem
CPC-FOCUS C12N · 10 areas
INNOV-PAR 55.8/100
CLAIMS-DENSE 24.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sachem, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Suzhou’s 55.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (18%) Velocity 20.0 pts (36%) Breadth 11.2 pts (20%) Claim depth 14.8 pts (27%)

Qualcomm Incorporated · highest

85
Suzhou Ribo Life… · this assignee

56
3D Lighting… · lowest

7

What this shows Suzhou's Innovation Score is 55.8/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Suzhou?

Each dot is one of Suzhou’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Suzhou’s own 24.7 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Suzhou vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Suzhou's grants concentrate

Suzhou Ribo Life Science Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 87.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Suzhou sits between Stowers Institute FOR Medical Research and Sachem, Inc..

Suzhou's three-year grant acceleration

Suzhou Ribo Life Science Co., Ltd. shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Stowers Institute…

16
Strategic Sports

16
Supfina Grieshabe…

16
Suture Ease

16
SVM Schultz Verwa…

16
Synedgen

16
Sysgration

16
Sachem

16
Suzhou Ribo Life… ◀

16

What this shows Suzhou holds 16 patents at rank #18,111, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Suzhou

By rank, the assignees closest to #18,111 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Suzhou's primary technology class.

Suzhou's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Suzhou Ribo Life Science Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.3%
2017	4	25.0%
2022	3	18.8%
2023	2	12.5%
2024	4	25.0%
2025partial year	2	12.5%

Which technologies does Suzhou Ribo Life Science Co., Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

C12Y - Enzymes 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Suzhou Ribo Life Science Co., Ltd.'s patent record in context - here's where to go next.

Suzhou Ribo Life Science Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 87.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #18,154 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Suzhou Ribo Life Science Co., Ltd. against Stowers Institute FOR Medical Research, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.